title: Lessons on prescribing and drug safety from the withdrawal of rofecoxib.
authors.forename: Mark
authors.initials: M
authors.lastname: Nelson
authors.forename: Flavia
authors.initials: F
authors.lastname: Cicuttini
mesh_terms: D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects*; D002985:Clinical Protocols; D016861:Cyclooxygenase Inhibitors / Q000009:adverse effects*; D004341:Drug Evaluation / Q000379:methods; D006801:Humans; D007783:Lactones / Q000009:adverse effects*; D010003:Osteoarthritis / Q000628:therapy; D011358:Product Surveillance, Postmarketing / Q000379:methods*; D013450:Sulfones / Q000009:adverse effects*
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D016861:Cyclooxygenase Inhibitors; D007783:Lactones; D013450:Sulfones; C116926:rofecoxib